Stepped Care in the Treatment of Trichotillomania
1 other identifier
interventional
60
1 country
1
Brief Summary
Trichotillomania (TTM), repetitive pulling out of one's own hair to the extent that noticeable hair loss occurs, is a distressing condition interfering substantially with functioning and quality of life. The longterm objective of this research is to determine whether psychological treatment of TTM could be disseminated more effectively by using a stepped care model in which less intensive interventions are tried first, with more intensive interventions used only if initial treatment proves insufficient. This project is a pilot study of the first two steps in a stepped care model of treatment. After baseline assessment, 50 participants with TTM will be randomly assigned to (a) Immediate condition, in which they are offered 10-week self-help treatment via an interactive website (Step 1) or (b) Wait List/Delayed Start condition, a 10-week wait list prior to being offered Step 1. In each condition, at the end of Step 1, participants will be offered 8 weeks of in-person habit reversal training provided by psychology graduate students (Step 2). TTM symptoms will be measured from baseline through a follow-up 3 months after the end of Step 2, as will depression, anxiety, quality of life, functional impairment , treatment utilization, and treatment satisfaction. The specific aims of the study are:
- 1.To gather preliminary data on the efficacy of web-based self-help, compared to wait list control;
- 2.To characterize the acceptability of stepped care to patients with TTM by assessing the proportion of enrolled participants who proceed from step 1 to step 2 treatment;
- 3.To evaluate the convergent validity of four decision rules for concluding that a patient with TTM has benefited sufficiently from a treatment step: (a) No longer meeting TTM diagnostic criteria; (b) Showing a 25% or greater reduction in total scores on self-report and clinician-rated TTM symptoms; (c) achieving complete abstinence from hair-pulling; and (d) clinically significant response on both self-report and clinician-rated TTM symptom measures
- 4.To evaluate the concurrent and predictive validity of criteria for sufficient benefit from a treatment step by relating them to treatment satisfaction, treatment utilization, and scores on a measure of functional impairment from TTM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Aug 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2010
CompletedFirst Posted
Study publicly available on registry
May 7, 2010
CompletedStudy Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedMay 27, 2013
May 1, 2013
2.3 years
May 5, 2010
May 23, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MGH-HS
self-report measure of trichotillomania symptom severity
10 weeks
Secondary Outcomes (2)
PITS
10 weeks
Step 2 completion
18 weeks
Study Arms (2)
Immediate
EXPERIMENTALAssigned immediately after baseline assessment to receive step 1 treatment (web-based self-help)
Wait list
NO INTERVENTIONAssigned to wait list for 10 weeks before receiving step 1 treatment.
Interventions
Eligibility Criteria
You may qualify if:
- years or older
- regular internet access
- if taking medications for Trichotillomania, on stable dose for at least 4 weeks
- have trichotillomania (DSM IV criteria except that increasing and decreasing tension with pulling not required)
You may not qualify if:
- current suicidality
- current major depression
- current psychosis
- current severe anxiety
- current substance abuse
- current psychotherapy focused on trichotillomania
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- American Universitylead
- National Institute of Mental Health (NIMH)collaborator
Study Sites (1)
American University
Washington D.C., District of Columbia, 20016-8062, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychology
Study Record Dates
First Submitted
May 5, 2010
First Posted
May 7, 2010
Study Start
August 1, 2010
Primary Completion
November 1, 2012
Study Completion
November 1, 2012
Last Updated
May 27, 2013
Record last verified: 2013-05